Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Harris & Harris' Heftier Holdings: Fool by Numbers

March 20th, 2007

Harris & Harris' Heftier Holdings: Fool by Numbers

Abstract:
On March 15, venture capital investment firm Harris & Harris (Nasdaq: TINY) released fourth-quarter earnings for the period ended Dec. 31.

* The Motley Fool Rule Breakers recommendation recorded six new investments in "tiny technology" (mostly nanotech) companies in 2006, with 14 additional follow-on investment rounds.
* The firm now has a stake in 31 different companies.
* Because Harris & Harris' purpose is "to achieve long-term capital appreciation, rather than current income, by making venture capital investments in early-stage companies" some of the traditional numbers below aren't a lot of help in describing the state of the company. The "Net asset value per outstanding share" row is a better measure.

Source:
fool.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project